{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:02:55Z","timestamp":1770483775519,"version":"3.49.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T00:00:00Z","timestamp":1331856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s12185-012-1050-9","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T02:16:55Z","timestamp":1331777815000},"page":"588-591","source":"Crossref","is-referenced-by-count":10,"title":["HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine"],"prefix":"10.1007","volume":"95","author":[{"given":"Yutaka","family":"Tsutsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiki","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,16]]},"reference":[{"key":"1050_CR1","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3748\/wjg.v17.i12.1531","volume":"17","author":"ML Manzano-Alonso","year":"2011","unstructured":"Manzano-Alonso ML, Castellano Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol. 2011;17:1531\u20137.","journal-title":"World J Gastroenterol"},{"key":"1050_CR2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2217\/imt.09.59","volume":"1","author":"Y Tsutsumi","year":"2009","unstructured":"Tsutsumi Y, Yamamoto Y, Tanaka J, et al. Prevention of hepatitis B virus reactivation under rituximab therapy. Immunotherapy. 2009;1:1053\u201361.","journal-title":"Immunotherapy"},{"key":"1050_CR3","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar1954","volume":"8","author":"M Vigna-Perez","year":"2006","unstructured":"Vigna-Perez M, Hern\u00e1ndez-Castro B, Paredes-Saharopulos O, Portales-P\u00e9rez D, Baranda L, Abud-Mendoza C, Gonz\u00e1lez-Amaro R. Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther. 2006;8:R83\u201392.","journal-title":"Arthritis Res Ther"},{"key":"1050_CR4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00432-003-0441-y","volume":"129","author":"A Klippstein","year":"2003","unstructured":"Klippstein A, Schneider CP, Sayer HG, Hoffken K. Pneumocystis carinii pneumonia as monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol. 2003;129:316\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1050_CR5","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/JVI.79.5.3038-3051.2005","volume":"79","author":"JJ Chang","year":"2005","unstructured":"Chang JJ, Wightman F, Bartholomeusz A, Ayres A, et al. Reduced hepatitis B virus (HBV)-specific CD4\u00a0+\u00a0T cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J Virol. 2005;79:3038\u201351.","journal-title":"J Virol"},{"key":"1050_CR6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3109\/10428194.2010.551573","volume":"52","author":"U Tapan","year":"2011","unstructured":"Tapan U, May SK, Fiore J, Kozyreva O. Reactivation of hepatitis B virus following bendamustine-containing chemotherapy in a patient with multiple myeloma. Leuk Lymphoma. 2011;52:916\u20138.","journal-title":"Leuk Lymphoma"},{"key":"1050_CR7","first-page":"1296","volume":"88","author":"M Picardi","year":"2003","unstructured":"Picardi M, Pane F, Quintarelli C, Giudice AD, de Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin\u2019s lymphomas: high prevalence of acquired viral genomic mutations. Haematologica. 2003;88:1296\u2013303.","journal-title":"Haematologica"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1050-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1050-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1050-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T06:16:15Z","timestamp":1593843375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1050-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,16]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1050-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,16]]}}}